FILE:CVH/CVH-8K-20120619070151.txt.gz
EVENTS:	Regulation FD Disclosure
TEXT:
ITEM: Regulation FD Disclosure
 
 
 
 
SECTION 7  REGULATION FD
Item 7.01          Regulation FD Disclosure.
 
Randy Giles, Executive Vice President and Chief Financial Officer of Coventry Health Care, Inc. (Coventry) will be making a presentation at the Wells Fargo Securities Healthcare Conference (the Conference) in Boston, Massachusetts that is scheduled for June 19-20, 2012. During the presentation and during subsequent investor meetings, Coventry intends to:
 
 
Coventrys presentation at the Conference is scheduled to begin at 9:00 a.m. Eastern time on June 19, 2012. Investors, analysts and the general public are invited to listen to this presentation over the Internet via Coventry's Investor Relations page at www.coventryhealthcare.com. The presentation slides and a replay of the presentation will be available at the same website until June 26, 2012.
 
The information in this Item 7.01 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.
 
Cautionary Statement:  This 8-K and the presentation contain forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are defined as statements that are not historical facts and include those statements relating to future events or future financial performance, including the guidance herein. Actual performance may be significantly affected by certain risks and uncertainties including those described in Coventrys Annual Report on Form 10-K for the year ended December 31, 2011, and Coventrys subsequent filings with the Securities and Exchange Commission, including its quarterly report on Form 10-Q for the quarter ended March 31, 2012.  Coventry undertakes no obligation to update or revise any forward-looking statements.
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 


